78 Steps Health Journal

References

1. Muller J (1838) Ueber den feinern Bau und die Formen der krankhaften Geschwulste. Reimer, Berlin

2. Gurbuz AK, Giardiello FM, Petersen GM et al (1994) Desmoid tumors in familial adenomatous polyposis. Gut 35:377-381

3. Tonelli F (1978) Abdominal desmoids and mesenteric fibromatosis in familial polyposis of the colon. Ital J Gastroenterol 10:27-36

4. Simpson RD, Harrison EG, Mayo CW (1964) Mesenteric fibromatosis in familial polyposis: a variant of Gardner's syndrome. Cancer 17:526-534

5. Richards RC, Rogers SW, Gardner EJ (1981) Spontaneous mesenteric fibromatosis in Gardner's syndrome. Cancer 47: 597-601

6. Clark SK, Johnson Smith TGP, Katz DE et al (1998) Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polypo-

sis. Br J Surg 85:970-975

7. Middleton SB, Clark SK, Matravers P et al (2003) Step-wise progression of familial adenomatous polyposis-associated desmoid precursor lesions demonstrated by a novel CT scoring system Dis Colon Rectum 46:481-485

8. Healey JC, Reznek RH, Clark SK et al (1997) MR appearances of desmoid tumours in familial adeno-matous polyposis. Am J Roentgenol 169:465-472

9. Brooks AP, Reznek RH, Nugent K et al (1994) CT appearances of desmoid tumors in familial adenoma-tous polyposis: further observations. Clin Radiol 49:601-607

10. Knudsen AL, Bulow S (2001) Desmoid tumour in familial adenomatous polyposis: a review of literature. Famil Cancer 1:111-119

11. Jarvinen HJ (1997) Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 153:379-383

12. Bertario L, Russo A, Sala P et al (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95:102-107

13. Penna C, Tiret E, Parc R et al (1993) Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet 177:263-268

14. Jones IT, Fazio VW, Weakley FL et al (1986) Desmoid tumors in familial polyposis coli. Ann Surg 204:94-97 Lofti AM, Dozois RR, Gordon H et al (1989) Mesen-teric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 4:30-36

15. Lofti AM, Dozois RR, Gordon H et al (1989) Mesen-teric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 4:30-36

16. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP et al (1994) Desmoid tumors in patients with familial adenomatous polyposis. Cancer 74:1270-1274

17. Kadmon M, Möslein G, Buhr H et al (1995) Desmoide bei Patienten mit familiärer adenomatöser Polyposis (FAP). Chirurg 66:997-1005

18. Heiskanen I, Jarvinen HJ (1997) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 11:157-162

19. Soravia C, Berk T, McLeod RS et al (2000) Desmoid disease in patients with familial adenomatous polypo-sis. Dis Colon Rectum 43:363-369

20. Ho JW, Chu KM, Tse CW, Yuen ST (2002) Phenotype and management of patients with familial adenoma-tous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong Med J 2002 Oct;8(5):342-347

21. Church JM (1998) Mucosal ischaemia caused by desmoid tumors in patients with familial adenoma-tous polyposis. Dis Colon Rectum 41: 661-663

22. Tulchinsky H, Keidar A, Strul H et al (2005) Extra-colonic manifestations of familial adenomatous poly-posis after proctocolectomy Arch Surg 140:159-163

23. Arvanitis ML, Jagelman DG, Fazio VW et al (1990) Mortality in patients with familial adenomatous poly-posis. Dis Colon Rectum 33:639-642

24. Iwama T, Myshima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at several organs: its rational treatment. Ann Surg 217:99-100

25. Bertario L, Presciuttini S, Sala P et al (1994) Causes of death and post-surgical survival in familial adenomatous polyposis: results from the Italian Registry of Familial Adenomatous Polyposis Writing Committee. Semin Surg Oncol 10:225-234

26. Sagar PM, Moslein G, Dozois RR (1998) Management of desmoid tumors in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 41:1350-1356

27. Parc Y, Piquard A, Dozois RR et al (2004) Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy. Ann Surg 239:378-382

28. Middleton SB, Frayling IF, Phillips RK (2000) Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 82:828-832

29. Li C, Bapat B, Alman BA (1998) Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin regulatory function in aggressive fibromatosis (desmoid tumors). Am J Pathol 153:709-714

30. McAdam WA, Goligher IC (1970) The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 57:618-631

31. Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185-1189

32. Sturt NJH, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832-1836

33. Caldwell EH (1976) Desmoid tumor: musculoaponeu-rotic fibrosis of the abdominal wall. Surgery 79:104-106

34. Eagel BA, Zntler-Munro P, Smith IE (1989 ) Mesenteric tumours in Gardner's syndrome: review of medical treatment. Postgrd Med J 65:497-501

35. Church JM, McGannon E (2000) Prior pregnancy ameliorates the course of intra-abdominal desmoid tumors in patients with familial adenomatous polypo-sis. Dis Colon Rectum 43:445-450

36. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1993) Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 53:5079-5082

37. Palmirotta R, Curia MC, Esposito DL et al (1995) Novel mutations and inactivations of both alleles of the AP gene in desmoid tumors. Hum Mol Genet 4:1979-1981

38. Caspari R, Olschwang S, Friedl W et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337-340

39. Couture J, Mitri A, Lagace R et al (2000) A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumour. Clin Genet 57:205-212

40. Eccles DM, van der Lujit R, Breukel C (1996) Heredi tary desmoid disease due to a frameshift mutation at codon 1924 of the gena APC. Am J Hum Mut 59:1193-1201

41. Tonelli F, Valanzano R, Brandi ML (1994) Pharmaco-logic treatment of desmoid tumors in familial adeno-matous polyposis: results of an in vitro study. Surgery 115:473-479

42. Picariello L, Fiorelli G, Benvenuti S et al (1997) In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells. Anticancer Res 17:2099-2104

43. Locci P, Bellocchio S, Lilli C et al (2001) Synthesis and secretion of transforming growth factor-ß1 by human desmoid fibroblast cell line and its modulation by toremifene. J Interferon and Cytokine Res 21:961-970

44. Waddell WR, Gerner RE, Reich MP (1983) Non steroidal anti-inflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 22:197-211

45. Kedar RP, Bourne TH, Powles TJ et al (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318-1321

46. Fisher B, Costantino JP, Redmand CK et al(1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537

47. Clark SK, Phillips RKS (1996) Desmoids in familial adenomatous polyposis. Br J Surg 83:1494-1504

48. Brooks MD, Ebbs SR, Colletta AA et al (1992) Desmoid tumors treated with triphenylethylenes. Eur J Cancer 28:1014-1018

49. Hansmann A., Adolph C, Vogel T et al (2003) Highdose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100:612-620

50. Tonelli F, Ficari F, Valanzano R et al (2003) Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori 89:391-396

51. Taketo M (1998) Cyclooxigenase-2 inhibitors in tumor-ogenesis (part i). J Natl Cancer Inst 90:1529-1536

52. Taketo M (1998) Cyclooxigenase-2 inhibitors in tumorogenesis (part II). J Natl Cancer Inst 90:1609-1620

53. Janne PA, Mayer RJ (2000) Chemoprevention of col-orectal cancer. N Engl J Med 342:1960-1968

54. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-235

55. Du Bois RN, Abramson SB, Crofford L et al (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073

56. Smith WL, Garavito RM, DeWitt (1996) Prostaglandin endo-peroxide H synthases (Cyclooxygenase)-1 and -2. J Biol Chem 271:33157-33160

57. Xe W, Robertson D, Simmons D ( 1992) Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res 25:249-265

58. Morrow JD, Roberts LJ (2001) Lipid-derived auta-coids. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 669-685

59. Roberts LJ, Morrow JD (2001) Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 687-731

60. Patrignani P, Filabozzi P, Patrono C (1982) Selective cumulative inhibition of platelet thromboxane production by low-doses aspirin in healthy subjects. J Clin Invest 69:1366-1372

61. FitzGerald GA, Oates JA, Hawiger J et al (1983) Endogenous biosynthesis of prostacyclin and throm-boxane and platelet function during chronic administration of aspirin in man. J Clin Invest 71:678-688

62. Roth GJ, Majerus P (1975) The mechanism of the effect of aspirin on human platelets: acetylation of a particulate protein fraction. J Clin Invest 56:624-632

63. Lecomte M, Laneuville O, Ji C et al (1994) Acetylation of human prostaglandin endo-peroxide synthase-2(cyclooxygenase-2) by aspirin. J Biol Chem 269:13207-13215

64. Cipollone F, Patrignani P, Greco A et al (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulatio 96:1109-1116

65. Vane JR (1994) Towards a better aspirin. Nature 367:215-216

66. Stolina M, Sharma S, Zu L et al ( 2000) Lung cancer cyclooxygenase-2 dependent inhibition of dendritic cell maturation and function. Pro Am Assoc Cancer Res 41:619 (abstract 620)

67. Tsujii M, DuBois RN (1995) Alteration in cellular adhesion and apoptosis in epithelial cells over-expressing prostaglandin endo-peroxide synthase 2. Cell 83:493-501

68. He TC, Chan TA, Vogelstein B et al (1999) PPAR-delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345

69. Afford S, Randhawa S (2000) Apoptosis. Mol Pathol 53:55-63

70. Bedi A, Pasricha PJ, Akhtar AJ et al (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55:1811-1816

71. Pasricha PJ, Bedi A, O'Connor K et al (1995) The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gas-troenterology 109:994-998

72. Uefuji K, Ichikura T, Shinomiya N et al (2000) Induction of apoptosis by JTE-522, a specific cyclooxyge-nase-2 inhibitor in human gastric cancer cell lines. Anticancer Res 20:4279-4284

73. Souza RF, Shewmake K, Beer DG et al (2000) Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human oesophageal adenocarci-noma cells. Cancer Res 60:5767-5772

74. Sumitani K, Kamijo R, Toyoshima T et al (2001) Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production. J Oral Pathol Med 30:41-47

75. Joki T, Heese O, Nikas DC et al (2000) Expression of cyclooxygenase 2 (COX!) in human glioma and in vitro inhibition by a specific COX 2 inhibitor, NS-398. Cancer Res 60:4926-4931

76. Tsubouchi Y, Mukai S, Kawaito Y et al (2000) Meloxicam inhibits the growth of non-small cell lung cancer. Anticancer Res 20:2867-2872

77. Molina MA, Sitja-Arnau M, Lemoine MG et al (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59:4356-4362

78. Marx J (2001) Cancer research. Anti-inflammatories inhibit cancer growth, but how? Science 291:581-582

79. Scorrano L, Penzo D, Petronilli V et al (2001) Arachi-donic acid causes cell death through the mitochondri-al permeability transition: implications for tumor necrosis factor-alpha apoptotic signalling. J Biol Chem 276:12035-12040

80. Grosch S, Tegeder I, Niederberg E et al (2001) COX independent induction of cell arrest and apoptosis in colon cancer cells by the selective COX 2 inhibitor celecoxib. FASEB J 15:2742-2744

81. Shureiqi I, Chen D, Lotan R et al (2000) 15-lipoxyge-nase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxyge-nase-2 in colon cancer cells. Cancer Res 60:6846-6850

82. Leahy KM, Ornberg RL, Wang et al. (2002) Cyclooxy-genase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 62:625-631

83. Tsujii M, Kawano S, Tsujii S et al (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716

84. Dannenberg AJ, Altorki NK, Boyle JO et al (2001) Cyclo-oxygenase 2: a pharmacological target for prevention of cancer. Lancet Oncol 2:544-551

85. Araki Y, Okamura S, Hussain S et al (2003) Regulation of cyclooxygenase-2 expression by the Wnt and Ras pathways. Cancer Res 63:728-734

86. Masferrer JL, Leahy KM, Koki AT et al (2000) Anti-angiogenic and anti-tumour activities of cyclooxyge-nase-2 inhibitors. Cancer Res 60:1306-1311

87. Jones MK, Wang H, Peskar BM et al (1999) Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-1423

88. Brueggemeier RW, Quinn AL, Parrett ML et al (1999) Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett 140:27-35

89. Tejpar S, Nollet F, Li C et al (1999) Predominance of -catenin mutations and -catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Onco-gene 18:6615-6620

90. Sparks AB, Morin PJ, Vogelstain B et al (1998) Mutational analysis of the APC/-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134

91. Williams CS, Smalley W, DuBois RN (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 100:1325-1359

92. Williams CS, Mann M, DuBois RN (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18:7908-7916

93. Oshima M, Dinchuk JE, Kargman SL et al (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2

94. Picariello L, Brandi ML, Formigli L et al (1998) Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. Eur J Pharm 360:105-112

95. Poon R, Smits R, Catherine L et al (2001) Cyclooxyge-nase-two (COX2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20:451-460

96. Tsukada K, Church JM, Jagelman DG et al (1992) Non-cytotoxic drug therapy for intra-abdominal desmoid tumors in patients with familial adenomatous polypo-sis. Dis Colon Rectum 35:29-33

97. Klein WA, Miller HH, Anderson M et al (1987) The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial poly-posis. Cancer 60:2863-2868

98. Waddell WR, Kirsch WM (1991) Testolactone, sulin-dac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 161:416-421

99. Geurs F, Kok TC (1993) Regression of a great abdominal desmoid tumor by interferon-alpha. J Clin Gas-trenterol 16:264-265

100. Heidemann J, Ogawa H, Otterson MF et al (2004) Anti-angiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum 47:118-122

101. Nakada J, Ubukata H, Goto Y et al (1997) Prednisolone therapy for intra-abdominal desmoid tumours in a patient with familial adenomatous polyposis. Gas-troenterol 32:255-259

102. Lindor NM, Dozois RR, Nelson H et al (2003) Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pir-fenidone. Am J Gastroenterol 98:1868-1874

103. Mace J, Biermann JS, Sondak V et al (2002) Response of extra-abdominal desmoid tumors to therapy with imatinib mesylate. Cancer 95:237-239

104. Tsukada K,Church JM, Jagelman DG et al (1991) Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 34:1090-1092

105. Patel SR, Evans HL, Benjamin RS (1992) Combination chemotherapy in adult desmoid tumors. Cancer 72:3244-3247

106. Lynch HT, Fitzgibbons R Jr, Chong S et al (1994) Use of doxorubicin and dacarbazine for the management of unresectable intraabdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 37:260-267

107. Schnitzler M, Cohen Z Blackstein M et al ( 1997) Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum 40:798-801

108. Risum S, Bulow S (2003) Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Dis 5:585-586

109. Okuno SH, Edmonson JH (2003) Combination chemotherapy for desmoid tumors. Cancer 97:1134-1135

110. Kono T, Tomita I, Chisato N et al (2004) Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case. Dis Colon Rectum 47:246-249

111. Gega M, Yanagi H, Yoshikawa R et al (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24(1):102-105

112. Patel SR, Benjamin RS (2006) Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol 24:1-2

113. Hartley JE, Church JM, Gupta S et al (2004) Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 47:334-340

114. Cohen ZBerg T ( 1998) Invited editorial. Dis Colon Rectum 41:1355-1356

115. Tonelli F, Batignani G, Ficari F et al (1997) Straight ileo-anal anastomosis with multiple ileal myotomies as an alternative to pelvic pouch. Int J Colorectal Dis 12:261-266

Was this article helpful?

0 0